Algebris Investments (UK)’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-287,378
Closed -$13.5M 37
2017
Q1
$13.5M Buy
287,378
+236,416
+464% +$11.3M 1.46% 19
2016
Q4
$2.45M Sell
50,962
-48,705
-49% -$2.23M 0.39% 40
2016
Q3
$3.95M Sell
99,667
-127,622
-56% -$4.8M 0.69% 29
2016
Q2
$8.07M Sell
227,289
-30,782
-12% -$1.2M 1.37% 17
2016
Q1
$10.1M Sell
258,071
-15,708
-6% -$587K 3.7% 8
2015
Q4
$11.8M Sell
273,779
-25,268
-8% -$1.11M 4.27% 9
2015
Q3
$12.6M Buy
299,047
+77,699
+35% +$3.63M 4.85% 5
2015
Q2
$11M Buy
221,348
+48,751
+28% +$2.31M 4.36% 7
2015
Q1
$7.78M Buy
172,597
+80,559
+88% +$3.62M 5.15% 5
2014
Q4
$4.44M Sell
92,038
-112,873
-55% -$5.36M 3.2% 10
2014
Q3
$9.81M Sell
204,911
-47,573
-19% -$2.31M 4.66% 4
2014
Q2
$12.5M Buy
252,484
+24,460
+11% +$1.14M 6.67% 4
2014
Q1
$10.7M Sell
228,024
-10,547
-4% -$485K 5.47% 4
2013
Q4
$11.5M Buy
238,571
+61,822
+35% +$2.77M 7.01% 2
2013
Q3
$7.4M Buy
176,749
+30,968
+21% +$1.33M 6.34% 4
2013
Q2
$5.95M Buy
+145,781
New +$5.36M 7.7% 6

Other funds holding MET

Algebris Investments (UK)'s MET Position: Q2 2017 in Review

Algebris Investments (UK) sold out of MetLife (MET) in Q2 2017, closing a stake of 287,378 shares — an estimated $13.5M sold.

Algebris Investments (UK) first reported a position in MET in Q2 2013 and held it in 16 quarters. The position peaked at $13.5M in Q1 2017. 1,029 funds tracked by Wall St. Rank hold MET as of Q2 2017.

  • Algebris Investments (UK) reported no remaining MetLife position as of Q2 2017 after selling out during the quarter.
  • Algebris Investments (UK) sold 287,378 MetLife shares in Q2 2017, an estimated $13.5M.
  • Algebris Investments (UK) first reported a position in MetLife in Q2 2013 and held it in 16 quarters.
  • Algebris Investments (UK)'s MetLife position peaked at $13.5M in Q1 2017.
  • 1,029 funds tracked by Wall St. Rank held MetLife as of Q2 2017.

Based on Algebris Investments (UK)'s 13F filing for Q2 2017.